Medking Lifescience Enhances Global Footprint with GMP-Compliant Contract Manufacturing and Advanced Vitamin D3 Pipeline
KALA AMB, INDIA — Medking Lifescience has announced a major operational scale-up, strengthening its position as a leading partner in contract pharmaceutical manufacturing. Driven by growing global demands for reliable outsourcing, the company has integrated advanced machinery into its state-of-the-art facility to specialize in high-yield, GMP-compliant manufacturing and an expanded line of therapeutic Vitamin D3 products.
By aligning its high-volume infrastructure with strict regulatory certifications, the company offers a robust, end-to-end supply chain solution for global healthcare brands.
World-Class GMP & GLP Certified Facility
Production occurs entirely within the company’s advanced manufacturing plant located in the Kala Amb Industrial Area. Operating under strict ISO 9001:2015, GMP, and GLP certifications, the facility maintains rigid environmental controls and quality protocols.
The plant features dedicated, ultra-modern Non β-Lactam production blocks optimized for both biological and non-biological formulations. This specialized layout eliminates cross-contamination risks and guarantees that every production run meets international pharmaceutical benchmarks.
Scalable Contract Manufacturing Solutions
With a portfolio exceeding 500 active formulations, Medking Lifescience has optimized its third-party contract manufacturing to support diverse product formats:
- Oral Solid Dosages: Scaled production of plain, film-coated, enteric-coated, and sustained-release (SR) tablets alongside hard and soft gelatin capsules.
- Liquid & Topical Lines: High-speed filling lines for oral syrups, suspensions, external ointments, and active therapeutic gels.
- Flexible Production Levels: Custom engineering lines tailored to handle small-batch clinical trials or large-scale commercial rollouts with consistent, on-time delivery.
This agile manufacturing framework helps external brands eliminate heavy capital investments in hardware while speeding up market delivery.
High-Stability Vitamin D3 Formulations
Alongside its contract services, the company has expanded its specialized nutraceutical division with a new generation of Vitamin D3 (Cholecalciferol) formulations. Addressing the widespread global prevalence of vitamin deficiencies, the research team developed highly stable, bioavailable variants across multiple delivery formats, including oral liquids, chewable tablets, and soft gelatin capsules.
These formulations utilize advanced lipid-matrix carriers. This technology protects the sensitive Vitamin D3 molecules from degradation caused by light and oxidation, ensuring long shelf life and precise dosing potency.
Streamlining the Global Supply Chain
Under streamlined leadership, the company integrates strict in-process quality control (IPQC) directly into the manufacturing floor. This guarantees medking life science total verification from raw material testing to final packaging. As international regulatory pressures mount, Medking Lifescience acts as a trusted, compliant partner that bridges complex formulation chemistry with efficient mass market distribution.